Shilpa Medicare share price target
You can expect 10% to 16% annually compounded return from this stock as per this stock past performance and current price. Current price (271) also good for short term investment. You can expect 20% return from current price within 1 year.
About Shilpa Medicare :
Shilpa Medicare Ltd. turned into incorporated within the yr 1987. Its contemporary share rate is 271. Its modern marketplace capitalization stands at Rs 2385 Cr.
Inside the contemporary zone, enterprise has mentioned Total Revenue of Rs. 1168 Cr and net income of Rs. 60.66 Cr. in the year of 2022. The corporation‘s management consists of VV Krishna Chaitanya, Piyush Goenka, Sirisha Chintapalli, Naresh Patwari, Sharath Reddy Kalakota, Vishnukant Bhutada, Omprakash Inani.
It is listed at the BSE with a BSE Code of 530549 , NSE with an NSE symbol of SHILPAMED and ISIN of INE790G01031. it’s Registered workplace is at Shilpa house,#12-6-214/ A1,Hyderabad RoadRaichur-584135, Karnataka. Their Registrars are ACC Ltd. it is auditors are Bohara Bhandari Bung & friends, Bohara Bhandari Bung & buddies LLP, Brahmayya & Co
| Mkt cap | 4.97TCr |
| 52-wk high | 670.40 |
| 52-wk low | 311.60 |
| P/E ratio | 124.19 |
| Div yield | – |
Share Target Price 2022 2023 2025 2030 of Shilpa Medicare
| Year | target 1 | target 2 |
|---|---|---|
| 2023 | 250 | 302 |
| 2024 | 295 | 386 |
| 2025 | 910 | 995 |
| 2026 | 1150 | 1250 |
| 2027 | 1320 | 1560 |
| 2028 | 1465 | 1620 |
| 2029 | 1685 | 1750 |
| 2030 | 1785 | 1950 |
Is SHILPA MEDICARE correct for long term investment?
As on 07-Jan-2022, the basics of SHILPA MEDICARE appearance average and for this reason you may watch for the outcomes to improve to make investments for long term ! See economic performance of SHILPA MEDICARE . Please have a look at the other parameters which includes Valuation, charge Momentum, information & company Governance and/or consult an investment guide earlier than taking an investment choice!
Is SHILPA MEDICARE UnderValued or overestimated?
As on 07-Jan-2022, SHILPA MEDICARE is Over Valued based at the estimates of intrinsic price and consequently won’t be an awesome buying opportunity in line with share Valuation at the moment!
what’s the Intrinsic value of SHILPA MEDICARE ?
As on 07-Jan-2022, the Intrinsic value of SHILPA MEDICARE is Rs. 222.94 determined based on Median of the 3 historic fashions.
fair value [Median EV / EBIDTA Model] : Rs. 172.12
fair value [Median EV / Sales Model] : Rs. 231.74
fair cost [Median Price / Sales Model] : Rs. 222.94
Median fair cost of SHILPA MEDICARE : Rs. 222.94
Is SHILPA MEDICARE buying and selling at a top rate or cut price?
As on 07-Jan-2022, SHILPA MEDICARE is trading at a premium of 157% based totally on the estimates of Median Intrinsic cost!